IL-17 antagonist(Alcamena Stem Cell Therapeutics Llc)

N/A

Report date: 2026/03/10 20:00:16
NME

Base Information

Drug NameIL-17 antagonist(Alcamena Stem Cell Therapeutics Llc)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionInterleukin 17A antagonists
TargetsInterleukin 17A
Therapy Area/IndicationsPlaque psoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlcamena Stem Cell Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesAlcamena Stem Cell Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsPlaque psoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A